Denali Therapeutics Inc. (DNLI): 8-K filed Nov 3, 2026

Form type

8-K

Filing date

Nov 3, 2026

Accession number

0001714899-26-000107

Filer

Denali Therapeutics Inc. (CIK 1714899)